MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$88,612K
(-95.57%↓ Y/Y)
Loss before income
tax expense
-$88,601K
Income tax expense
$11K
(-98.70%↓ Y/Y)
Benefit from r&d credit
$7,463K
Revenue
$559K
(-98.70%↓ Y/Y)
Other income, net
$3,480K
Operating loss
-$91,077K
Gross profit
$344K
Foreign currency
(loss)/gain, net
-$8,467K
Cost of sales
$215K
(-98.18%↓ Y/Y)
Research and development
costs
$67,753K
General and
administrative expenses
$22,344K
(-16.89%↓ Y/Y)
Restructuring charges
$1,324K
Back
Back
Income Statement
source: myfinsight.com
Silence Therapeutics plc (SLN)
Silence Therapeutics plc (SLN)